» Articles » PMID: 17554059

High-risk HLA Allele Mismatch Combinations Responsible for Severe Acute Graft-versus-host Disease and Implication for Its Molecular Mechanism

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2007 Jun 8
PMID 17554059
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

In allogenic hematopoietic stem-cell transplantation, an effect of HLA locus mismatch in allele level on clinical outcome has been clarified. However, the effect of each HLA allele mismatch combination is little known, and its molecular mechanism to induce acute graft-versus-host disease (aGVHD) remains to be elucidated. A total of 5210 donor-patient pairs who underwent transplantation through Japan Marrow Donor Program were analyzed. All HLA-A, -B, -C, -DRB1, -DQB1, and -DPB1 alleles were retrospectively typed in all pairs. The impacts of the HLA allele mismatch combinations and amino acid substitution positions in 6 HLA loci on severe aGVHD were analyzed. A total of 15 significant high-risk HLA allele mismatch combinations and 1 HLA-DRB1-DQB1 linked mismatch combinations (high-risk mismatch) for severe aGVHD were identified, and the number of high-risk mismatches was highly associated with the occurrence of severe aGVHD regardless of the presence of mismatch combinations other than high-risk mismatch. Furthermore, 6 specific amino acid substitution positions in HLA class I were identified as those responsible for severe aGVHD. These findings provide evidence to elucidate the mechanism of aGVHD on the basis of HLA molecule. Furthermore, the identification of high-risk mismatch, that is, nonpermissive mismatch, would be beneficial for the selection of a suitable donor.

Citing Articles

Occlusion of TCR binding to HLA-A*11:01 by a non-pathogenic human alloantibody.

Hamidinia M, Gu Y, Ser Z, Brzostek J, Tay N, Yap J Cell Mol Life Sci. 2025; 82(1):94.

PMID: 40009199 PMC: 11865395. DOI: 10.1007/s00018-025-05614-y.


Novel Scoring System for Ranking Hematopoietic Stem Cell Transplantation.

Baxter-Lowe L, Wang T, Kuxhausen M, Spellman S, Maiers M, Lee S Clin Transplant. 2024; 38(11):e15478.

PMID: 39512128 PMC: 11840805. DOI: 10.1111/ctr.15478.


Experimental Data on PIRCHE and T-Cell Reactivity: HLA-DPB1-Derived Peptides Identified by PIRCHE-I Show Binding to HLA-A*02:01 in vitro and T-Cell Activation in vivo.

Peereboom E, Maranus A, Timmerman L, Geneugelijk K, Spierings E Transfus Med Hemother. 2024; 51(3):131-139.

PMID: 38867810 PMC: 11166409. DOI: 10.1159/000537789.


Prognostic impact of HLA supertype mismatch in single-unit cord blood transplantation.

Sugio T, Uchida N, Miyawaki K, Ohno Y, Eto T, Mori Y Bone Marrow Transplant. 2024; 59(4):466-472.

PMID: 38238452 DOI: 10.1038/s41409-023-02183-1.


Challenges and concepts in the diagnosis and management of ocular graft-versus-host disease.

Tappeiner C, Heiligenhaus A, Halter J, Miserocchi E, Bandello F, Goldblum D Front Med (Lausanne). 2023; 10:1133381.

PMID: 36891189 PMC: 9987249. DOI: 10.3389/fmed.2023.1133381.